Collagen Type II
Undenatured type II collagen (UC-II)
TL;DR
Undenatured type II collagen at 40 mg/day works by oral tolerance, not by supplying building blocks. Randomised trials in knee osteoarthritis show it outperforming glucosamine plus chondroitin, at a fraction of the dose.
Ideal For
- Knee osteoarthritis with pain and stiffness
- Exercise-related joint discomfort in active adults
- People who did not respond to glucosamine and chondroitin
- Those wanting a low-pill-burden joint option
Avoid If
- Chicken or egg allergy, depending on source
- Expecting rapid relief
- Autoimmune disease on immunomodulating therapy, without advice
- Pregnancy or breastfeeding
Frequently Asked Questions
Overview
Undenatured type II collagen is the most mechanistically interesting joint supplement, because it works in a way that has nothing to do with the usual "supplies the raw materials" logic. The dose is the giveaway: 40 mg a day, roughly a thousandth of the ten grams of hydrolysed collagen peptides people take for skin. That is because UC-II is not absorbed as amino acids for cartilage synthesis — it interacts with Peyer's patches in the small intestine, where intact type II collagen epitopes induce oral tolerance, expanding regulatory T cells that migrate to joints and downregulate the inflammatory response against native cartilage collagen. Denaturing the protein destroys the epitopes and the effect, which is why processing matters absolutely and why hydrolysed collagen is a different product entirely. Clinically, a randomised trial in knee osteoarthritis compared UC-II 40 mg against glucosamine 1,500 mg plus chondroitin 1,200 mg and found greater WOMAC improvement with UC-II, and further trials in both osteoarthritis and exercise-related joint discomfort in healthy adults point the same way. The evidence base is smaller than that for glucosamine and heavily concentrated among trials involving the ingredient manufacturer, which is the main reason for caution. Onset takes around three months.
How It Works
- Intact epitopes induce oral tolerance via Peyer's patches
- Expands regulatory T cells that traffic to joints
- Suppresses local inflammation and matrix metalloproteinase activity
- Denaturing or hydrolysing the protein abolishes the effect
Quick Facts
- 40 mg/day, not 10 g — a completely different mechanism from collagen peptides
- Beat glucosamine plus chondroitin head-to-head in a randomised trial
- Requires around 90 days for full effect
- Most trials involve the ingredient manufacturer
Benefits & Outcomes
No linked outcomes yet. Research is ongoing.
Supporting Research6 studies
UC-II Undenatured Type II Collagen for Knee Joint Flexibility: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Study
Undenatured type II collagen 40 mg/day improved knee extension range of motion and reduced activity-related joint discomfort versus placebo in healthy adults.
Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial
Crowley DC, Lau FC, Sharma P
UC-II reduced WOMAC, VAS and Lequesne scores significantly more than glucosamine plus chondroitin
Undenatured type II collagen (UC-II) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers
Lugo JP, Saiyed ZM, Lau FC
UC-II extended time to onset of exercise-induced knee joint pain and improved knee extension versus placebo
Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study
Lugo JP, Saiyed ZM, Lane NE
Undenatured type II collagen reduced total WOMAC score significantly more than placebo and than glucosamine plus chondroitin at 180 days.
A multicenter, double-blind, randomized, controlled phase III clinical trial of chicken type II collagen in rheumatoid arthritis
Wei W, Zhang LL, Xu JH +3 more
Chicken type II collagen produced ACR20 response rates lower than methotrexate but with significantly fewer adverse events.
Oral type II collagen treatment in early rheumatoid arthritis: a double-blind, placebo-controlled, randomized trial
Sieper J, Kary S, Sorensen H +10 more
No significant differences in disease activity between oral type II collagen and placebo groups.
Safety Information
Potential Side Effects
Very well tolerated at 40 mg. Occasional mild gastrointestinal upset, headache or constipation, at rates close to placebo in trials.
Contraindications
Chicken allergy, given the usual source is chicken sternal cartilage. Caution in autoimmune disease where immune modulation is already being managed pharmacologically.
Drug Interactions
- Immunosuppressants — theoretical interaction given the immunological mechanism
- NSAIDs — no adverse interaction; often used together during onset
Pregnancy & Breastfeeding
Pregnancy: insufficient_data
Breastfeeding: insufficient_data
Dosage Guidelines
Dosage Used in Studies
40-40 mg
Best Time to Take
Once daily on an empty stomach, typically at bedtime
Best Form
UC-II undenatured type II collagen, glycosylated
Bioavailability
Deliberately not absorbed systemically — the mechanism requires intact epitopes reaching gut-associated lymphoid tissue.
Forms Compared
UC-II (undenatured)
Hydrolysed collagen peptides
Chicken sternal cartilage extract
Food & Timing
Empty stomach improves survival of intact epitopes to the small intestine; bedtime dosing is the trial convention.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.